Articles From: RXi Pharmaceuticals Appoints Peter Campochiaro M.D. to its Scientific Advisory Board to Penford Reports Third Quarter Fiscal Year 2014 Financial Results


SAN DIEGO, July 7, 2014 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) , a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced that it will relocate the company's corporate headquarters to a new leased facility in northern San Diego at 16745 W Bernardo Drive, Suite 200, San Diego, CA 92127.
Sign-up for Conatus Pharmaceuticals to Relocate Corporate Headquarters investment picks
- Pre-NDA meeting scheduled with FDA in July DUBLIN and RALEIGH, N.C. , July 7, 2014 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL) , and BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today positive top-line results from its pivotal Phase III efficacy study of BEMA buprenorphine in opioid-experienced patients.
Sign-up for Endo and BioDelivery Sciences announce positive top-line results from the Phase III clinical trial of BEMA® buprenorphine in opioid-experienced patients with chronic pain investment picks
HOUSTON , July 7, 2014 /PRNewswire/ -- CARBO Ceramics Inc. (NYSE: CRR) announced today that it plans to release earnings results for the second quarter of 2014 on July 31, 2014 , and will host a conference call at 10:30 a.m. Central Time ( 11:30 a.m. Eastern) that day.
Sign-up for CARBO Schedules Second Quarter 2014 Earnings Call for July 31, 2014 investment picks
GUELPH, Ontario , July 7, 2014 /PRNewswire/ -- Canadian Solar Inc. (the "Company", or "Canadian Solar") (NASDAQ: CSIQ) , one of the world's largest solar power companies, today announced that its wholly owned subsidiary, Canadian Solar Solutions Inc., on Monday, June 30 , completed the sale of the 10 MW AC Val Caron solar power plant (" Val Caron ") valued at over C$60 million to One West Holdings Ltd., an affiliate of Concord Green Energy (" Concord "). The Val Caron 10 MW AC solar power plant is located in the city of Greater Sudbury, Ontario .
Sign-up for Canadian Solar Completes the Sale of 10 MW Solar Power Plant to Concord Green Energy investment picks
BELLEVUE, Wash.
Sign-up for Expedia Comment On eLong investment picks
2014/7/7
Average Quarterly Production 20,630 bopd CALGARY , July 7, 2014 /PRNewswire/ - Bankers Petroleum Ltd.
Sign-up for Bankers Petroleum Operational Update for the Second Quarter 2014 investment picks
MCLEAN, Va., July 7, 2014 (GLOBE NEWSWIRE) -- Iridium Communications Inc. (Nasdaq:IRDM) today announced that its application to the International Maritime Organization (IMO) for the provision of mobile satellite communications in the Global Maritime Distress and Safety System (GMDSS) was reviewed by the IMO Sub-Committee on Navigation, Communications and Search and Rescue (NCSR). The application will now proceed to the Maritime Safety Committee (MSC) at its next meeting in November, before advancing to a group of experts for comprehensive technical and operational evaluation.
Sign-up for Iridium's Application to Provide Global Maritime Distress and Safety System Services Receives Support From International Maritime Organization Sub-Committee investment picks
Results of Manure Sterilization Trials Meet EPA Rules for Class A Waste TAMPA, Fla.
Sign-up for MagneGas® Confirms EPA Requirements for Manure Processing Achieved investment picks
WALNUT, California , July 7, 2014 /PRNewswire/ -- VIASPACE Inc. (OTCQB: VSPC) today announced that the company has signed a Giant King Grass Supply Contract with ReSource BioEnergy, Inc. to supply Giant King Grass for its bioenergy projects in Jamaica .
Sign-up for ReSource BioEnergy Plants VIASPACE Giant KingTM Grass for BioEnergy Development in Jamaica investment picks
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Auxilium Pharmaceuticals, Inc. (“Auxilium” or the “Company”) (Nasdaq: AUXL) relating to the proposed acquisition by QLT, Inc. (“QLT”). Click here to learn more about the investigation http://brodsky-smith.com/781-auxl-auxilium-pharmaceiticals-inc.html , or call: 877-534-2590.
Sign-up for SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Auxilium Pharmaceuticals, Inc. in Connection with the Sale of the Company investment picks
NEW YORK , July 7, 2014 /PRNewswire/ -- Greenhill & Co., Inc. (NYSE: GHL) , a leading independent investment bank, announced today that Carlo Bosco has joined the Firm as a Principal in the Restructuring Group in London .
Sign-up for Greenhill Expands the Restructuring Group as Carlo Bosco Joins the London Office investment picks
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced today that the U.S. Food and Drug Administration (FDA) has granted Accelerated Approval of Beleodaq™ for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). This indication is approved under accelerated approval based on Tumor Response Rate and Duration of Response .
Sign-up for FDA Grants Spectrum Pharmaceuticals Accelerated Approval of Beleodaq™ (belinostat) for Injection investment picks
Moody's Corporation (NYSE:MCO) will release second quarter 2014 results before the start of NYSE trading on Friday, July 25, 2014.
Sign-up for Dates Set for Moody's Earnings Release and Investor Teleconference investment picks
Bristol-Myers Squibb Company (NYSE:BMY) announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Daklinza ® (daclatasvir), a potent, pan-genotypic NS5A replication complex inhibitor ( in vitro ), and Sunvepra ® (asunaprevir), a NS3/4A protease inhibitor, providing a new treatment that can lead to cure for many patients in Japan who currently have no treatment options.
Sign-up for Japan Approves First All-Oral, Interferon- and Ribavirin-Free Hepatitis C Treatment, Daklinza® (daclatasvir) and Sunvepra® (asunaprevir) Dual Regimen investment picks
REDWOOD CITY, Calif., July 7, 2014 (GLOBE NEWSWIRE) -- Informatica Corporation (Nasdaq:INFA) , the world's number one independent leader in data integration software, today announced it will release its second quarter 2014 earnings results on July 24, 2014, after the close of the market.
Sign-up for Informatica Sets Date to Announce Second Quarter Earnings Results investment picks
SAN DIEGO, July 7, 2014 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS) , a leading National Security Solutions provider, announced today that its Modular Systems Division (KMSD) recently received approximately $32 million in contract awards for specialty products and systems in support of certain National Security programs, including Radar, Missile System and Warfighter support programs.
Sign-up for Kratos Receives $32 Million in National Security Program Awards investment picks
2014/7/7
ALMELO, The Netherlands , July 7, 2014 /PRNewswire/ -- Sensata Technologies Holding N.V. (NYSE: ST) announced today that a subsidiary has agreed to acquire DeltaTech Controls for a total enterprise value of $190 million .
Sign-up for Sensata Technologies Announces The Acquisition of DeltaTech Controls investment picks
2014/7/7
MEDNAX, Inc. (NYSE: MD), will host an investor conference call and webcast on Thursday, July 31, 2014 at 10:00 a.m. EDT, to discuss results from operations for the quarter and the six months ended June 30, 2014.
Sign-up for MEDNAX 2014 Second Quarter Conference Call/Webcast Scheduled for Thursday, July 31, 2014 investment picks
SHANGHAI , July 7, 2014 /PRNewswire/ -- JinkoSolar Holding Co., Ltd.
Sign-up for JinkoSolar Partners with Tsinghua University as the Sole PV Facility Provider in the Construction of the 'Dream Grid' Plan investment picks
SAN DIEGO, July 7, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) , a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced it has launched two new clinical development initiatives for MYDICAR®, its lead product candidate, in patients with end-stage renal disease (ESRD) undergoing surgery for arteriovenous fistula (AVF) creation in preparation for hemodialysis, and in advanced heart failure patients with systolic dysfunction that were previously excluded from MYDICAR trials due to pre-existing levels of neutralizing antibodies.
Sign-up for Celladon Corporation Announces New Clinical Development Initiatives for MYDICAR(R) investment picks
Teradyne, Inc. (NYSE:TER) announces the Magnum V, the next generation memory test solution in the Nextest Magnum product line designed for massively parallel memory test in the Flash, DRAM and multi chip package (MCP) marketplace.
Sign-up for Teradyne Introduces the Magnum V Memory Test System investment picks
OXFORD, United Kingdom and MARLBOROUGH, Mass., July 7, 2014 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) , a global, commercial-stage diagnostics company committed to improving patient care by providing advanced, innovative tests in the field of immunology, today announced that Louis O'Dea, MB, BCh, BAO, has joined the company as Chief Medical Officer.
Sign-up for Oxford Immunotec Appoints Louis O'Dea Chief Medical Officer investment picks
2014/7/7
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- European stock markets retreated on Monday after a surprise, steep drop in German industrial production data sparked worries that Europe's economic engine is losing steam.
Sign-up for UPDATE: European stocks drop after weak German production data investment picks
LOUDON, Tenn., July 7, 2014 (GLOBE NEWSWIRE) -- Malibu Boats, Inc., (Nasdaq:MBUU) (" Malibu Boats " or the " Company "), a leading designer, manufacturer and marketer of performance sport boats, today announced that, subject to market and other conditions, it and certain selling stockholders (the " Selling Stockholders ") intend to offer 4,000,000 shares of its Class A Common Stock, consisting of 3,195,887 shares to be offered by the Company and 804,113 shares to be offered by the Selling Stockholders.
Sign-up for Malibu Boats, Inc. Announces Public Offering of 4,000,000 Shares investment picks
2014/7/7
By Neil MacLucas and Andrew Morse ZURICH -- Cement giants Lafarge SA and Holcim Ltd.
Sign-up for Lafarge, Holcim to sell units as they seek merger OK investment picks
2014/7/7
By Ilan Brat MADRID -- Spanish technology firm Gowex SA said on Sunday it had filed for bankruptcy protection after the company's chairman acknowledged falsifying accounts and resigned.
Sign-up for Gowex files for bankruptcy protection; chairman quits investment picks
NEW YORK, July 7, 2014 (GLOBE NEWSWIRE) -- Warren Resources, Inc. ("Warren" or the "Company") (Nasdaq:WRES) today announced that it has executed a purchase and sale agreement to acquire essentially all of the Marcellus assets of Citrus Energy Corporation ("Citrus") and two additional working interest owners for $352.5 million.
Sign-up for Warren Resources, Inc. Announces Acquisition of the Marcellus Assets of Citrus Energy Corporation for $352.5 Million investment picks
Penford Corporation (Nasdaq:PENX), a leader in ingredient systems for food and industrial markets, today reported third quarter and year-to-date fiscal year 2014 results.
Sign-up for Penford Reports Third Quarter Fiscal Year 2014 Financial Results investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: RXi Pharmaceuticals Appoints Peter Campochiaro M.D. to its Scientific Advisory Board to Penford Reports Third Quarter Fiscal Year 2014 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices